Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04087954
Other study ID # 5115
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date December 22, 2018

Study information

Verified date September 2019
Source Fakeeh College for Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Backgrounds: Research evidence suggests that people diagnosed with schizophrenia (PDwS) experience higher level of stigma compared with other forms of mental illness, and they are prone to internalize stereotype, which exacerbates severity of psychiatric symptoms, reduces their psychosocial treatment adherence. The purpose of the study to evaluate the effectiveness of stigma reduction program on the perceived stigma, psychiatric symptoms, compliance with psychosocial intervention and self-efficacy.

Methods: A randomized controlled trial was conducted from November 2017 to December 2018 with 278 PDwS. Participants aged 18 years or older with DSM-IV schizophrenia or schizoaffective disorder, from four outpatient mental health clinics in Jordan, were randomly assigned to receive 13 sessions of a booklet form of stigma reduction program (n = 140) (psycho-education, cognitive behavioural therapy and social skills training), and treatment as usual [TAU] (intervention, n = 140), or TAU (control, n = 138). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at six months follow-up. The primary outcome measure was change in stigma perception. Secondary outcomes were psychiatric symptoms, compliance with psychosocial interventions and self-efficacy.


Recruitment information / eligibility

Status Completed
Enrollment 278
Est. completion date December 22, 2018
Est. primary completion date December 22, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Eligibility Criteria

- Adults aged 18 or over diagnosed with schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) (American Psychiatric Association, 2013).

- All participants had to be able to read and write English or Arabic

- Willing and able to consent.

Exclusion criteria were:

- People diagnosed with schizophrenia who had a learning disability, with known organic mental disorder, substance abuse

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Stigma reduction program
Participants in the intervention group received treatment as usual, supported with stigma reduction program booklets each fortnight for 26 weeks. The stigma reduction program includes three modules; psychoeducation, cognitive behavioural therapy and social skills training. The program aims to enhance patient understanding of Schizophrenia and foster communication skills which supposed to increase self-confidence and strengthen communication networking with society. Psychoeducation module purposes at introducing about the concepts of schizophrenia, providing patient with essential information about schizophrenia, including nature of disease, sign/symptoms, treatment strategies, side effects of medication. Social Skills Training (SST) module purposes at fostering communication skills among patient diagnosed with schizophrenia. This assists the participants to be re-integrated in the society and build a harmonious atmosphere in the community.

Locations

Country Name City State
Jordan Ministry of Health Amman

Sponsors (1)

Lead Sponsor Collaborator
Fakeeh College for Medical Sciences

Country where clinical trial is conducted

Jordan, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome was stigma perception measured by the Internalised Stigma of Mental Illness Scale (ISMI) The primary outcome was stigma perception measured by the Internalised Stigma of Mental Illness Scale (ISMI). This scale has 29 items measure service user experience of stigma. It is composed of 5 subscales: alienation (6 items), stereotype endorsement (7 items), discrimination experience (5 items), social withdrawal (6 items), and stigma resistance (5 items). Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree). The five stigma resistance subscale items are reverse-coded, and also serve as a validity check. The stigma resistance score is calculated by subtracting the actual value from five. Therefore, stigma resistance displays the same direction of correlation as the other four subscales. A high total score on the ISMI scale indicates more severe internalized stigmatization. The internal consistency is (a=0.90) and test-retest reliability (r=0.92) have been reported for the ISMI (Ritsher & Phelan, 2004). November 2017-December 2018 (up to 11 months)
Secondary Positive and Negative Symptom Scale (PANSS) PANSS measures 30 clinical symptoms of schizophrenia; each symptom is scored from 1 indicating absence of psychopathology to 7 indicating severe psychopathology, with higher scores indicating poorer mental health status. Internal reliability and criterion-related validity are 0.77 (positive scale) and 0.77 (negative scale), and 0.52 with the Clinical Global Impression scale (CGI) (Kay, Fiszbein, & Opfer, 1987). The primary researcher (AH) attended training delivered by the PANSS Institute, USA, and trained the outcomes assessors. An inter-rater reliability checked prior to the study, between assessors was 0.75 and inter-rater reliability (intra-class correlation (ICC) was 0.79. This tool was administered in English by the primary researcher (AH) and research assistants. November 2017-December 2018 (up to 11 months)
Secondary The Psychosocial Treatment Compliance Scale (PTCS) The Psychosocial Treatment Compliance Scale (PTCS) (Tsang et al., 2006) has 17 items rated from "(1) never" to "(5) always". The PTCS has the "participation" (12 items) and "attendance" (5 items) subscales. The scale has two main parts, participation which indicates the level of participants engagement and participation in the psychosocial interventions (e.g., "was willing to follow therapists' instructions"). However, attendance measures that participants commitment to scheduled appointments (e.g., "attended prescribed psychosocial treatment on time"). The scale has good psychometric properties (internal consistency: a=.87-.96; test-retest reliability: ICC=.86-.90) were demonstrated for the subscales (Tsang et al., 2006). November 2017-December 2018 (up to 11 months)
Secondary The Chinese General Self-efficacy Scale (CGSS) The Chinese General Self-efficacy Scale (CGSS) developed by (Chiu & Tsang, 2004). This scale has a 10-item. Scoring system ranges from "(1) Not at all true" to "(4) Exactly true". Participants with higher score reflect better general self-efficacy. The CGSS demonstrated good internal consistency (a=0.92-0.93) and test-retest reliability (ICC=0.75-0.94) (Chiu & Tsang, 2004). November 2017-December 2018 (up to 11 months)
See also
  Status Clinical Trial Phase
Recruiting NCT05755165 - Adolescent Depression: Video Ads on Instagram N/A
Completed NCT03750864 - Innovative Approach to Reduce Lung Cancer Stigma N/A
Completed NCT05124665 - Interrupting HIV and TB Stigma in the Household in Uganda N/A
Completed NCT03695393 - Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs N/A
Recruiting NCT04420442 - Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars N/A
Completed NCT05596305 - Outcomes of Anti Stigma Educational Intervention of Ungraduated Medical Students N/A
Not yet recruiting NCT06434805 - An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students N/A
Recruiting NCT02280889 - Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Active, not recruiting NCT05907174 - Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care N/A
Recruiting NCT06402929 - Honest, Open, Proud - College for Post-Secondary Students With Mental Health Challenges N/A
Recruiting NCT06316804 - Mobile Mental Health Stigma Reduction Intervention Among Black Adults N/A
Recruiting NCT05785169 - Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination N/A
Not yet recruiting NCT05415891 - The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta N/A
Completed NCT05980832 - Effect of Peer-Supported Psychosocial Skills Training in Individuals With Chronic Mental Disorder N/A
Completed NCT04644978 - European Study on the Attitude of Psychiatrists Towards Their Patients
Completed NCT02101697 - Reducing AIDS Stigma Among Health Professionals in India N/A
Completed NCT05271903 - Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania N/A
Completed NCT05935345 - Addressing Nonsuicidal Self-injury in Schools N/A
Completed NCT05770804 - Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels N/A
Completed NCT03231761 - Impact of Video Presentations on Medical Students' Attitudes Toward Mental Illness N/A